Consistent chromosomal translocations involving the c-myc cellular oncogene and one of the three immunoglobulin loci have been reported in human Burkitt's lymphoma, in induced mouse plasmacytoma (MPC) and in spontaneously arising rat immunocytoma (RIC) (reviewed by Croce & Nowell, 1985; Potter, 1986; Pear et al., 1986; Enrietto, 1987) . Translocation is believed to play an important role in the development of these tumours (Klein, 1986) . Multiple myeloma (MM) in humans is a neoplasm of B cells at a differentiation stage comparable to that of MPC and RIC. However, a rearrangement of the c-myc oncogene was reported only in three cases of MM (Gazdar et al., 1986; Selvanayagam et al., 1988) and in one case of plasma cell leukaemia (Yamada et al., 1983) .
In recent years, several transplantation lines derived from spontaneously arising MM in ageing C57BL mice became available in our institute. This mouse MM resembles the human disease very closely in several aspects (Radl et al., 1988) . It is of interest to investigate whether the cells of the experimental ST MM series contain c-myc abnormalities of the MPC type or whether they resemble the human MM in this respect. The results of this study show that rearrangement of the c-myc oncogene was found in the bone marrow of only one of the ST MM transplantation lines and was possibly due to a late event in the progression of this malignancy.
Materials and methods

Mice
Male and female C57BL/KaLwRij mice from the colony of the Institute for Experimental Gerontology in Rijswijk, The Netherlands, were used in this study. Detailed information on this inbred strain of mice has been published elsewhere (Zurcher et al., 1982; Van Zwieten et al., 1981) .
ST mouse multiple myeloma
The different ST MM originated spontaneously in ageing C57BL/KaLwRij mice (Radl et al., 1988 Cell preparations Cell suspensions from bone marrow and spleen were prepared as described (Croese et al., 1987) . The percentage of 5T MM cells in these samples was estimated by morphology, cytoplasmic immunoperoxidase staining and by analysis of the cellular DNA content. Cytoplasmic examination was performed on cytocentrifuge preparations (Hijmans et al., 1965) of the suspensions, using PO-labelled antibodies (Nordic Immunological Laboratories, Tilburg, The Netherlands) specific for the isotype of the given 5T MM immunoglobulin ( Table I ). The DNA from bone marrow or spleen cells was stained with propidium iodine (PI) according to Taylor (1980) . The cellular DNA content was analysed by measuring the PI fluorescence intensity by a fluorescence-activated cell sorter (FACS-II, Becton Dickinson, Mountain View, CA, USA).
Southern blot analysis
High molecular weight DNA was extracted from 0.5-1.0 x I0 bone marrow, spleen or ascitic cells by the method of Kunkel et al. (1977) . The chromosomal DNA was digested with the restriction enzymes HindIII or EcoRI under conditions recommended by the manufacturer (Gibco-BRL, Breda, The Netherlands). Digested DNA was electrophoresed on 0.6-0.8% agarose gels in buffer consisting of 89 mM Tris, 89 mM boric acid and 0.2 mM EDTA, pH 8.0 and transferred to Gene Screen Plus filters in 0.4 N NaOH and 0.6 M NaCI (Reed & Mann, 1985) . Filters were prehybridised for 2 h at 65'C in a solution of 50 mM Tris/HCl, pH 7.5, 10 mM EDTA, 1 M NaCl, 1% SDS, 0.1% sodium pyrophosphate, 0.2% Ficoll, 0.2% polyvinylpyrrolidone, 100 xg ml-salmon sperm DNA and hybridised in the same solution overnight with 25 ng of c-myc probe, with specific activity of approximately 109 c.p.m. tig-' DNA, a 1.4 kb ClaI-EcoRI fragment containing the third exon of the human c-myc gene, which was random-primed 32P-labelled (Boehringer, Mannheim, FRG) . After hybridisation, filters were washed to a stringency of 0.5 x SSC (I SSC = 75 mM NaCl, 7.5 mM sodium citrate, 1% SDS) 0.1% sodium pyrophosphate at 65'C, and exposed overnight at -70'C to Kodak XAR-5 X-ray films. A schema of the murine c-myc gene and the relevant restriction sites are shown in Figure 1 . (Figure 2) . However, the 5T2 MM showed an additional hybridising fragment of 5.4 kb (HindIII) and 15 kb (EcoRI). The same pattern was observed when DNA from 5T2 MM cells originating from an animal with an ascitic form of 5T2 MM was investigated (Figure 3 ). This indicates that the c-myc rearrangement took place in the common donor of both sublines in an earlier generation.
Three other ST MM were shown to be able to grow in the peritoneal cavity of unprimed recipient mice: 5T14, 5T30 and 5T33 MM. The DNA isolated from the 5T30 and 5T33 MM showed only the germ line configuration, while that of the 5T14 MM produced an additional band of 1.3 kb (HindIII) and 5.8 kb (EcoRI) (Figure 3 ).
Discussion
The most common structural alteration in human Burkitt's lymphoma, mouse plasmacytoma and rat immunocytoma is an interruption of the c-myc gene upstream of its second exon (Mushinski et al., 1987) . In many MPC, the breakpoint is within the first intron between El and E2, in some MPC, the breakpoint in c-myc occurs 300-500 base pairs 5' of El (Potter, 1986 5T2 MM bearing mouse in the 24th transplantation generation and in none of the seven other ST MM, which were of earlier generations. The bone marrow is the major site of this malignancy in both man and the C57BL mouse (Radl et al., 1988) . Therefore, any structural abnormalities within different oncogenes, if they were of basic importance for the development of this malignancy, should primarily be present in the MM cells of the bone marrow compartment. In humans, rearrangement of the c-myc oncogene was found only in three cases (one of them being a very progressive IgA MM involving pleural tissue) and in one case of plasma cell leukaemia (Gazdar et al., 1986; Selvanayagam et al., 1988; Yamada et al., 1983) . In this context, it is interesting that in the 5T14 MM, being able to grow in the peritoneal tissue, a rearrangement of the c-myc was found in ascitic cells but not in the bone marrow cells. Moreover, the 5T2 MM in an advanced stage can develop features of a plasma cell leukaemia (Ebbeling et al., 1985) . These (RadI et al., 1985 (RadI et al., , 1988 , including possibly also the c-myc pattern. Therefore, these ST MM series offer an excellent experimental model for studies on the aetiology and pathogenesis of multiple myeloma. In addition, this mouse B cell malignancy, expressed mainly at the differentiation stage of a plasma cell, shows clear-cut differences when compared with MPC and RIC, both also involving a B cell at its last differentiation stage (Radl et al., 1988) . Investigation of these differences may shed new light on the possible microheterogeneity of the plasma cell and its malignant counterparts evolving either into local plasmacytoma or diffuse multiple myeloma.
